Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary Vascular Signaling in Pulmonary Hypertension: Potential Role of Endothelial Ca<sup>2+</sup> Signaling in Cellular Senescence and Inflammasome Activation.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Guidelines for evaluating endothelial function in vascular tissue.

American journal of physiology. Heart and circulatory physiology·2026
Same author

eNAMPT/TLR4 signaling drives PAH cellular phenotypic switching and lung vascular remodeling.

Cell communication and signaling : CCS·2025
Same author

Store-operated Ca<sup>2+</sup> entry is involved in endothelium-to-mesenchymal transition in lung vascular endothelial cells.

American journal of physiology. Lung cellular and molecular physiology·2025
Same author

Store-operated Ca <sup>2+</sup> entry is involved in endothelium-to-mesenchymal transition in lung vascular endothelial cells.

bioRxiv : the preprint server for biology·2024
Same author

Enhanced lung endothelial glycolysis is implicated in the development of severe pulmonary hypertension in type 2 diabetes.

American journal of physiology. Lung cellular and molecular physiology·2024

Related Experiment Video

Updated: May 23, 2026

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells
06:15

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells

Published on: November 19, 2016

Mitochondrial function in vascular endothelial cell in diabetes.

Meenal Pangare1, Ayako Makino

  • 1University of Illinois at Chicago, Chicago, IL 60612, USA.

Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi
|April 17, 2012
PubMed
Summary

Diabetic complications stem from endothelial dysfunction, where altered mitochondrial function, including ROS production and calcium overload, impairs vascular health and cell survival.

More Related Videos

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Related Experiment Videos

Last Updated: May 23, 2026

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells
06:15

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells

Published on: November 19, 2016

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Area of Science:

  • Vascular Biology
  • Mitochondrial Physiology
  • Diabetic Complications

Background:

  • Diabetic patients frequently develop micro- and macrovascular complications, with endothelial dysfunction playing a key role.
  • Endothelial dysfunction contributes to vascular tension, atherosclerosis, hypertension, ischemia, and stroke in diabetes.

Purpose of the Study:

  • To review the physiological and pathophysiological roles of mitochondria in endothelial function.
  • To focus on the specific implications of mitochondrial changes in diabetes-related vascular complications.

Main Methods:

  • Review of existing literature on mitochondrial function and endothelial cells.
  • Analysis of evidence linking mitochondrial morphology and function to endothelial dysfunction.
  • Examination of the role of mitochondrial dynamics, biogenesis, and autophagy.

Main Results:

  • Mitochondrial fragmentation (via altered fission/fusion) disrupts endothelial function.
  • Impaired mitochondrial biogenesis and autophagy lead to accumulation of damaged mitochondria, promoting cell death.
  • Increased mitochondrial reactive oxygen species (ROS) production and calcium overload negatively impact endothelial function and cell survival.

Conclusions:

  • Mitochondrial dysfunction is a critical factor in diabetic endothelial dysfunction and associated vascular complications.
  • Targeting mitochondrial pathways may offer therapeutic strategies for managing diabetic vascular disease.